Biopharma entrepreneurs! Our expert VC panelists are answering your questions, reflecting on the impact on investments during Covid-19 and what the future holds for IPOs and M&A. Walk through top biopharma fund initial assessment through due diligence and investment. Learn where investors are finding technology, how they are valuing and deciding on opportunities, and how they look at team versus asset/technology.
Jonathan Norris, Managing Director, Healthcare Practice, SVB
Otello Stampacchia, PhD, Founder, Omega Funds
Deborah Palestrant, PhD, Partner, Head of 4:59, 5AM Ventures
Cami Samuels, Partner, Venrock
Dan Estes, PhD, General Partner - Frazier Healthcare Partners